Dynamic42 with “Research for the Future” at MEDICA 2021
At MEDICA, our Managing Director Dr. Martin Raasch presented a microphysiological lung model with integrated immune cells, which we have been working on since 2017.
At MEDICA, our Managing Director Dr. Martin Raasch presented a microphysiological lung model with integrated immune cells, which we have been working on since 2017.
The award underlines that we guarantee high quality standards in the development, production, and distribution of biochips as well as in the services of organ-on-chip models.
With our organ-on-chip platform, chemical and toxicological tests can be carried out on human cell cultures.
2021: Three years ago we started with Dynamic42! We look back on a successful time that was characterized by growth. Learn more about us!
From August 23 to September 2, 2021, the online conference WC11 took place under the motto "3Rs in Transition: From Development to Application". We report to you from the conference.
We want to take the plunge across the pond! We participated in the intensive workshop Step USA Virtual. It is a very successful!
Congratulations to our managing director Dr. Martin Raasch!
We were happy that Dynamic42 received one of the coveted lecture places. Our managing directors presented Dynamic42 GmbH in a pitch. We were also represented with our digital trade fair stand in the Innovation Arena.
From May 5 to May 7, 2021, the online conference 3D Cell Culture took place around the latest scientific findings and current model innovations in the fields of synthetic biology, tumor research, 3D models and microphysiological systems. We were there!
Organ-on-chip technology provides efficient and ethical methods for food and drug testing.